A Randomized, Three-way, Cross-over Study to Assess the Efficacy of a Dual-hormone Closed-loop System With XeriSol Glucagon vs Closed-loop System With Insulin Only vs a Predictive Low Glucose Suspend System
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Glucagon (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 09 Sep 2020 Primary endpoint (Percent of time with sensed glucose 70 mg/dl) has been met.
- 09 Sep 2020 Results published in the Diabetes Care
- 11 Jun 2019 Interim analysis results (n=7) evaluating the safety of Xerisol are presented at the 79th Annual Scientific Sessions of the American Diabetes Association